BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND FANCG, ENSG00000221829, 2189, O15287, XRCC9, FAG AND Treatment
7 results:

  • 1. Natural History of Incidental Enhancing Nodules on Cone-Beam Computed Tomography during Transarterial Therapy of Hepatocellular Carcinoma.
    Elboraey M; Devcic Z; Montazeri SA; Li X; Lewis AR; Ritchie CA; Frey GT; Paz-Fumagalli R; McKinney JM; Toskich BB
    J Vasc Interv Radiol; 2021 Aug; 32(8):1186-1192.e1. PubMed ID: 33901694
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Can oesophagectomy be performed for patients with oesophageal carcinoma and concomitant liver cirrhosis? A retrospective study based on a propensity-matched cohort.
    Wang ZQ; Deng HY; Yang YS; Wang Y; Hu Y; Yuan Y; Wang WP; Chen LQ
    Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):442-447. PubMed ID: 28520878
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.
    Heetfeld M; Chougnet CN; Olsen IH; Rinke A; Borbath I; Crespo G; Barriuso J; Pavel M; O'Toole D; Walter T;
    Endocr Relat Cancer; 2015 Aug; 22(4):657-64. PubMed ID: 26113608
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Surgical treatment of lymph node metastases from hepatocellular carcinoma.
    Kobayashi S; Takahashi S; Kato Y; Gotohda N; Nakagohri T; Konishi M; Kinoshita T
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):559-66. PubMed ID: 21331804
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.
    Palagyi A; Neveling K; Plinninger U; Ziesch A; Targosz BS; Denk GU; Ochs S; Rizzani A; Meier D; Thasler WE; Hanenberg H; De Toni EN; Bassermann F; Schäfer C; Göke B; Schindler D; Gallmeier E
    Mol Cancer; 2010 May; 9():127. PubMed ID: 20509860
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.
    Alberts SR; Suman VJ; Pitot HC; Camoriano JK; Rubin J
    J Gastrointest Cancer; 2007; 38(1):10-4. PubMed ID: 19065716
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Sebaceous carcinoma of the eyelid associated with retinoblastoma.
    Kivelä T; Asko-Seljavaara S; Pihkala U; Hovi L; Heikkonen J
    Ophthalmology; 2001 Jun; 108(6):1124-8. PubMed ID: 11382640
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.